The Cytomegalovirus Retinitis market was valued at USD 194.27 Billion in 2024 and is expected to reach USD 300.41 Billion by 2032, growing at a CAGR of 5.6% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.